Multivalent pneumococcal polysaccharide-protein conjugate composition
AssigneeWyeth
InventorsWilliam P. Hausdorff, George Rainer Siber, Peter R. Paradiso, A. Krishna Prasad
Life of this patent
Estimating the term…
Loading patent…
AssigneeWyeth
InventorsWilliam P. Hausdorff, George Rainer Siber, Peter R. Paradiso, A. Krishna Prasad
Estimating the term…
An immunogenic composition having 13 distinct polysaccharide-protein conjugates and optionally, an aluminum-based adjuvant, is described. Each conjugate contains a capsular polysaccharide prepared from a different serotype of Streptococcus pneumoniae (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) conjugated to a carrier protein. The immunogenic composition, formulated as a vaccine, increases coverage against pneumococcal disease in infants and young children globally, and provides coverage for serotypes 6A and 19A that is not dependent on the limitations of serogroup cross-protection. Also described is a method for making an immunogenic conjugate comprising Streptococcus pneumoniae serotype 1 polysaccharide covalently linked to a carrier protein, the method including partial de-O-acetylation of the polysaccharide by mild hydrolysis in an alkaline pH buffer.
A method for making an immunogenic conjugate comprising Streptococcus pneumoniae serotype 1 polysaccharide covalently linked to a carrier protein, the method comprising:
A method for making an immunogenic conjugate comprising Streptococcus pneumoniae serotype 1 polysaccharide covalently linked to a carrier protein, the method comprising:
A method for making an activated Streptococcus pneumoniae serotype 1 polysaccharide, the method comprising:
Dependencies are inferred from the claim text.